Eulerpool Terminal
The edge that pays for itself.
Current Concord Biotech forecasts and price targets in August 2026
Ø Analyst Price Targets
1,448.40 INR
-0.42 %
Median
1,443.30 INR
-0.77 %
Max
1,764.00 INR
Min
1,181.70 INR
Last Price
1,454.50 INR
Buy
8
Hold
2
Sell
0
The average target price for Concord Biotech is 1,448.40 INR. (-0.42 % below the current price)
The median price target of Concord Biotech is 1,443.30 INR.
Stock analysts from many renowned investment banks are closely examining the Concord Biotech stock. They conclude their professional Concord Biotech stock analyses with a clear recommendation for the Concord Biotech stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 7 | 3 | 0 | — |
| 2026-02-01 | 8 | 2 | 0 | 1,448.40 INR |
| 2026-02-01 | 8 | 2 | 0 | 1,542.75 INR |
| 2026-01-01 | 7 | 3 | 0 | 1,542.75 INR |
| 2025-12-01 | 7 | 3 | 0 | 1,700.85 INR |
| 2025-12-01 | 7 | 3 | 0 | 1,742.93 INR |
Concord Biotech Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Concord Biotech in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 11.57 B INR | 2.88 B INR | 27.50 INR |
| 2027e | 12.54 B INR | 3.32 B INR | 31.70 INR |
| 2028e | 14.74 B INR | 4.11 B INR | 39.31 INR |